Sustainable Value Creation in Commercialisation of Innovation: The Case Auria Biobank

Hanna Lehtimäki, Ilpo Helén, Karoliina Snell, Päivi Eriksson, Tero Montonen

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Kuvaus

The purpose of this study is to examine how different logics of commercialisation are part of sustainable value creation in an emerging area of healthcare. This paper presents an inductive interpretative case study to examine the emerging field of personalised medicine from the perspective of a biobank seeking to create value on its depository of tissue samples, patient records, and digitised data. This study increases our understanding of the challenges and opportunities faced by a company when developing innovations in healthcare. It contributes to the literature on the commercialisation of innovation by exploring how sustainable value creation in an emerging industry builds on both planned and emergent commercialisation activities and how different logics of commercialisation are a part of sustainable value creation in personalised medicine.
Alkuperäiskielienglanti
LehtiInternational Journal of Entrepreneurship and Innovation Management
Vuosikerta23
Numero5
Sivut451-465
Sivumäärä15
ISSN1368-275X
DOI - pysyväislinkit
TilaJulkaistu - 4 heinäkuuta 2019
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3141 Terveystiede
  • 5141 Sosiologia
  • 512 Liiketaloustiede

Lainaa tätä

Lehtimäki, Hanna ; Helén, Ilpo ; Snell, Karoliina ; Eriksson, Päivi ; Montonen, Tero. / Sustainable Value Creation in Commercialisation of Innovation : The Case Auria Biobank. Julkaisussa: International Journal of Entrepreneurship and Innovation Management. 2019 ; Vuosikerta 23, Nro 5. Sivut 451-465.
@article{ece64fe4ffd044c2ae5a4d90fba4198c,
title = "Sustainable Value Creation in Commercialisation of Innovation: The Case Auria Biobank",
abstract = "The purpose of this study is to examine how different logics of commercialisation are part of sustainable value creation in an emerging area of healthcare. This paper presents an inductive interpretative case study to examine the emerging field of personalised medicine from the perspective of a biobank seeking to create value on its depository of tissue samples, patient records, and digitised data. This study increases our understanding of the challenges and opportunities faced by a company when developing innovations in healthcare. It contributes to the literature on the commercialisation of innovation by exploring how sustainable value creation in an emerging industry builds on both planned and emergent commercialisation activities and how different logics of commercialisation are a part of sustainable value creation in personalised medicine.",
keywords = "3141 Health care science, 5141 Sociology, 512 Business and Management",
author = "Hanna Lehtim{\"a}ki and Ilpo Hel{\'e}n and Karoliina Snell and P{\"a}ivi Eriksson and Tero Montonen",
year = "2019",
month = "7",
day = "4",
doi = "10.1504/IJEIM.2019.102035",
language = "English",
volume = "23",
pages = "451--465",
journal = "International Journal of Entrepreneurship and Innovation Management",
issn = "1368-275X",
publisher = "Inderscience Enterprises",
number = "5",

}

Sustainable Value Creation in Commercialisation of Innovation : The Case Auria Biobank. / Lehtimäki, Hanna; Helén, Ilpo; Snell, Karoliina; Eriksson, Päivi ; Montonen, Tero.

julkaisussa: International Journal of Entrepreneurship and Innovation Management, Vuosikerta 23, Nro 5, 04.07.2019, s. 451-465.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Sustainable Value Creation in Commercialisation of Innovation

T2 - The Case Auria Biobank

AU - Lehtimäki, Hanna

AU - Helén, Ilpo

AU - Snell, Karoliina

AU - Eriksson, Päivi

AU - Montonen, Tero

PY - 2019/7/4

Y1 - 2019/7/4

N2 - The purpose of this study is to examine how different logics of commercialisation are part of sustainable value creation in an emerging area of healthcare. This paper presents an inductive interpretative case study to examine the emerging field of personalised medicine from the perspective of a biobank seeking to create value on its depository of tissue samples, patient records, and digitised data. This study increases our understanding of the challenges and opportunities faced by a company when developing innovations in healthcare. It contributes to the literature on the commercialisation of innovation by exploring how sustainable value creation in an emerging industry builds on both planned and emergent commercialisation activities and how different logics of commercialisation are a part of sustainable value creation in personalised medicine.

AB - The purpose of this study is to examine how different logics of commercialisation are part of sustainable value creation in an emerging area of healthcare. This paper presents an inductive interpretative case study to examine the emerging field of personalised medicine from the perspective of a biobank seeking to create value on its depository of tissue samples, patient records, and digitised data. This study increases our understanding of the challenges and opportunities faced by a company when developing innovations in healthcare. It contributes to the literature on the commercialisation of innovation by exploring how sustainable value creation in an emerging industry builds on both planned and emergent commercialisation activities and how different logics of commercialisation are a part of sustainable value creation in personalised medicine.

KW - 3141 Health care science

KW - 5141 Sociology

KW - 512 Business and Management

U2 - 10.1504/IJEIM.2019.102035

DO - 10.1504/IJEIM.2019.102035

M3 - Article

VL - 23

SP - 451

EP - 465

JO - International Journal of Entrepreneurship and Innovation Management

JF - International Journal of Entrepreneurship and Innovation Management

SN - 1368-275X

IS - 5

ER -